By expenditures
| Name | Title | Type |
|---|---|---|
| Katharine Balukas | Principal | Auditee |
| Maura McQueeney | President and CEO | Auditee |
| Dawn Michelizzi | CHIEF FINANCIAL OFFICER | Auditee |
| Tammy Michaud | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 348160 | 2024 | 2025-03-25 | Berry Dunn McNeil & Parker LLC | $1.61M |
| 300747 | 2023 | 2024-03-29 | Berry Dunn McNeil & Parker LLC | $1.52M |
| 39252 | 2022 | 2023-03-30 | Berry Dunn McNeil & Parker LLC | $1.58M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 348160 | 2024 | 2025-03-25 | 1106555 | 2024-002 | Significant Deficiency | Yes | AB |
| 348160 | 2024 | 2025-03-25 | 530113 | 2024-002 | Significant Deficiency | Yes | AB |
| 300747 | 2023 | 2024-03-29 | 966312 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 966311 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 966310 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 966309 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 966308 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 966307 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 966306 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 966305 | 2023-003 | Significant Deficiency | Yes | I |
| 300747 | 2023 | 2024-03-29 | 966304 | 2023-002 | Significant Deficiency | - | AB |
| 300747 | 2023 | 2024-03-29 | 966303 | 2023-002 | Significant Deficiency | - | AB |
| 300747 | 2023 | 2024-03-29 | 966302 | 2023-002 | Significant Deficiency | - | AB |
| 300747 | 2023 | 2024-03-29 | 966301 | 2023-002 | Significant Deficiency | - | AB |
| 300747 | 2023 | 2024-03-29 | 389870 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 389869 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 389868 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 389867 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 389866 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 389865 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 389864 | 2023-004 | Significant Deficiency | Yes | L |
| 300747 | 2023 | 2024-03-29 | 389863 | 2023-003 | Significant Deficiency | Yes | I |
| 300747 | 2023 | 2024-03-29 | 389862 | 2023-002 | Significant Deficiency | - | AB |
| 300747 | 2023 | 2024-03-29 | 389861 | 2023-002 | Significant Deficiency | - | AB |
| 300747 | 2023 | 2024-03-29 | 389860 | 2023-002 | Significant Deficiency | - | AB |
| 300747 | 2023 | 2024-03-29 | 389859 | 2023-002 | Significant Deficiency | - | AB |
| 39252 | 2022 | 2023-03-30 | 618161 | 2022-002 | Material Weakness | - | L |
| 39252 | 2022 | 2023-03-30 | 618160 | 2022-002 | Material Weakness | - | L |
| 39252 | 2022 | 2023-03-30 | 618159 | 2022-002 | Material Weakness | - | L |
| 39252 | 2022 | 2023-03-30 | 618158 | 2022-001 | Material Weakness | - | I |
| 39252 | 2022 | 2023-03-30 | 41719 | 2022-002 | Material Weakness | - | L |
| 39252 | 2022 | 2023-03-30 | 41718 | 2022-002 | Material Weakness | - | L |
| 39252 | 2022 | 2023-03-30 | 41717 | 2022-002 | Material Weakness | - | L |
| 39252 | 2022 | 2023-03-30 | 41716 | 2022-001 | Material Weakness | - | I |